Tag: TRQ

Blue Horseshoe Stocks: More Options Success

Options Reviews

Our prowess in identifying some of the best quick strike options idea around is always showing itself. We signaled two more fresh options ideas in yesterday morning’s premarket report, and despite a down day for the markets, our ideas managed to buck the trend, and produce single-session gain opportunities of a significant nature.

BIDU and MDT were both post-earnings plays and they both yielded some nice potential profits, to the tune of multi-bag moves in every single set of  targeted contracts:

Baidu, Inc. BIDU Weekly $113-116 Calls 
$113 Calls – Range: 1.18-2.51 – Max Gain: 113%
$114 Calls – Range: .87-2.03  – Max Gain: 133%
$115 Calls – Range: .67-1.65 – Max Gain: 146%
$116 Calls – Range: .52-1.38 – Max Gain: 165%
_____

Medtronic plc MDT Weekly $107-109 Calls
$107 Calls – Range: .90-3.00 – Max Gain: 233%
$108 Calls – Range: .29-2.10 – Max Gain: 624%
$109 Calls – Range: .25-1.45 – Max Gain: 480%
_____

More Fresh Ideas:
TGT Weekly $98-101 Calls
LOW Weekly $107-110 Calls

Extended Watchlist:
NTRR, CDIX, REI, TRQ, EROS, ADOM, ARDX, OBLN, DQ

Blue Horseshoe Stocks: New Options Ideas & More

Teva Pharmaceutical Industries Ltd. TEVA

We’re very interested in TEVA as a potential bottom bounce play. The stock registered new 52-week lows midway through last week, and has exhibited a solid level of support. Trending up slightly in the premarket, we’re going to be tracking a pair of June options contracts to coincide with what could easily be a significant rebound.

Our specific targets are going to be the TEVA 06/28 $12.50 & $13 Calls, which could present us with sizable opportunities to profit
_____

Sprint Corp. S

We’re also going to set our sights on a range of Sprint options as the company attempts to gain FCC and DOJ approval on its $26B proposed merger with T-Mobile. The review period ends in June, but we’re more interested in the short term capability of the stock to provide us with quick strike chances. We’re going to radar the S Weekly $7-8 Calls.

Adverum Biotechnologies, Inc. ADVM – Review

A stock we recently began tracking, ADVM has been in a fairly continual uptrend since we signaled it for observation on the morning of April 17th. In the last month, the stock has made considerable bullish strides.

From the low we observed on the day of our initial alert, at 5.44, ADVM has gone on to record a high of 9.17. That comes out to an increase of 69%

Extended Watchlist:
TOPS, GERN, GMO, AMRH, TRQ, CREX, FUN, ICON, SQQQ, TMUS, INDY

Blue Horseshoe Stocks: EBIO, HRB Updates & More

H&R Block, Inc. HRB – Options Update

The options idea we formulated and passed along to our readers on Friday for HRB was far away our best play of the week, and an excellent way to wrap it up. Our specific target range that we highlighted in this case was the HRB 06/17 $21-23 Calls. and we ended up seeing monstrous moves out of each of the contained contracts.

$21 Calls – Trading Range: .60-3.30 – Max Gain: 450%
$22 Calls – Trading Range: .15-2.30 – Max Gain: 1430%
$23 Calls– Trading Range: .05-1.30 – Max Gain: 2500%

______

Added Reminder:

The other options play we set our sights on in Friday morning’s report was Global Blood Therapeutics,Inc. GBT – 06/17 $20-30 Calls. We saw some moderate activity as the stock ran early in the day, before tapering off. As they don’t expire until the end of this week, we just wanted to reiterate the possibility of more pronounced moves if GBT maintains support at 22.00 or above.

Eleven Biotherapeutics, Inc. EBIO 

The last time we reminded folks about our interest in EBIO, a stock that has appeared in our reports many times in the past, was on June 3rd. On that day, we were commenting on an earlier alert we put out on it back in May while EBIO’s PPS was at .80, after seeing it run up to its then-high of 2.10.

It ended up topping out at 2.60 on the afternoon of the 3rd, and has since been under light consolidation. It reached a support level of 1.62 on Friday, before beginning to rebound, and this morning it has gapped up hard in the premarket to a new high of 3.55 on the strength of an attractive PR (link below).

From our observed low in May, it represents an overall increase of 344% We’ll want to see the stock’s previous resistance level of 2.60 hold as support on any early pullbacks.

Extended Watchlist:
AROPQ, EXAD, TRQ, GIG, AMRS, QURE,
FLXN(Big Insider Buying)